0910-AH62 202204 Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Nonprescription Drug Product With an Additional Condition for Nonprescription Use

The proposed rule is intended to increase access to nonprescription drug products. The proposed rule would establish requirements for a drug product that could be marketed as a nonprescription drug product with an additional condition that an applicant must implement to ensure appropriate self-selection, appropriate actual use, or both by consumers.

]]> Other Significant Previously Published in The Unified Agenda Proposed Rule Stage No No 21 CFR 201.67 21 CFR 314.56 21 CFR 314.81 21 CFR 314.125 21 CFR 314.127 21 U.S.C. 321 21 U.S.C. 352 21 U.S.C. 355 21 U.S.C. 371 42 U.S.C. 262 42 U.S.C. 264 ... Yes NPRM 06/00/2022 No Businesses None No No No No Chris Wheeler Supervisory Project Manager 0910 Food and Drug Administration FDA 301 796-0151 cderomp@fda.hhs.gov 10903 New Hampshire Avenue, Building 51, Room 3330, Silver Spring MD 20993